WATERTOWN, Mass., May 21, 2026–(BUSINESS WIRE)–Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has…
Browsing: Biotechnology
AMR Bio has announced its launch as a clinical-phase biotechnology company, advancing the XF platform it acquired from Destiny Pharma…
Employment falls in April as markets increase bets on further RBA rate hikes Midday Market Summary Australian shares rebounded strongly…
Danaher CorporationDHR continues to benefit from strength in its Biotechnology segment. In the first quarter of 2026, the segment’s core…
Privately-held UK based AMR Bio has announced its launch as a clinical phase biotechnology company focused on one of the…
Amgen has announced a planned CFO transition while analysts at Piper Sandler recently adjusted their price target after a solid…
Forlong Biotechnology, a clinical-stage biotech company focused on developing cytokine therapies for patients with severe unmet medical needs, announced the…
MARSEILLE, France–(BUSINESS WIRE)–#Biotech–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company…
Press Release – University of Canterbury A fully automated laboratory designed for biotechnology experiments in microgravity is preparing for testing…
SB Investment Advisers (UK) Ltd reported a sale of 2,168,884 shares of Vir Biotechnology (VIR 1.02%) in its May 15,…